Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalini Arunogiri

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Drug and Alcohol Dependence|August 31, 2020
Harms associated with inhalant misuse in adolescent females - a review of the pre-clinical and clinical evidenceRose Crossin, Shalini Arunogiri
Journal of Substance Abuse Treatment|December 11, 2020
Depot buprenorphine during COVID-19 in Australia: Opportunities and challengesShalini Arunogiri, Nicholas Lintzeris
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|July 4, 2015
Anxiety and substance use disorders: a worrying combinationShalini Arunogiri, Dan I Lubman
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 7, 2016
Should ketamine be used for the clinical treatment of depression?Shalini Arunogiri, Nicholas A Keks, Judy Hope
Australian Journal of General Practice|February 3, 2020
The assessment and management of gamma hydroxybutyrate use in general practiceVicky Phan, Shalini Arunogiri, Dan I Lubman
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|September 13, 2019
Substance use and borderline personality disorder: fostering hope in the face of complexityFiona Donald, Shalini Arunogiri, Dan I Lubman
Frontiers in Global Women'S Health|March 7, 2022
Barriers to Accessing Addiction Treatment for Women at Risk of HomelessnessDavinia Rizzo, Temika Mu, Sophia Cotroneo, et al.
Maturitas|July 25, 2022
Systematic review and narrative synthesis of cognition in perimenopause: The role of risk factors and menopausal symptomsChen Zhu, Natalie Thomas, Shalini Arunogiri, et al.
Internal Medicine Journal|April 20, 2026
Case for caution in expanding attention deficit hyperactivity disorder prescribingMax Hankin, Anthony Hew, Shalini Arunogiri, et al.
Addictive Behaviors|April 26, 2021
Methamphetamine use and technology-mediated psychosocial interventions: A mini-reviewAdam J Rubenis, Amanda L Baker, Shalini Arunogiri
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Drug and Alcohol Dependence|August 31, 2020
Harms associated with inhalant misuse in adolescent females - a review of the pre-clinical and clinical evidenceRose Crossin, Shalini Arunogiri
Journal of Substance Abuse Treatment|December 11, 2020
Depot buprenorphine during COVID-19 in Australia: Opportunities and challengesShalini Arunogiri, Nicholas Lintzeris
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|July 4, 2015
Anxiety and substance use disorders: a worrying combinationShalini Arunogiri, Dan I Lubman
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 7, 2016
Should ketamine be used for the clinical treatment of depression?Shalini Arunogiri, Nicholas A Keks, Judy Hope
Australian Journal of General Practice|February 3, 2020
The assessment and management of gamma hydroxybutyrate use in general practiceVicky Phan, Shalini Arunogiri, Dan I Lubman
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|September 13, 2019
Substance use and borderline personality disorder: fostering hope in the face of complexityFiona Donald, Shalini Arunogiri, Dan I Lubman
Frontiers in Global Women'S Health|March 7, 2022
Barriers to Accessing Addiction Treatment for Women at Risk of HomelessnessDavinia Rizzo, Temika Mu, Sophia Cotroneo, et al.
Maturitas|July 25, 2022
Systematic review and narrative synthesis of cognition in perimenopause: The role of risk factors and menopausal symptomsChen Zhu, Natalie Thomas, Shalini Arunogiri, et al.
Internal Medicine Journal|April 20, 2026
Case for caution in expanding attention deficit hyperactivity disorder prescribingMax Hankin, Anthony Hew, Shalini Arunogiri, et al.
Addictive Behaviors|April 26, 2021
Methamphetamine use and technology-mediated psychosocial interventions: A mini-reviewAdam J Rubenis, Amanda L Baker, Shalini Arunogiri
Pageof 9